Replay available

Fulgent Genetics, Inc. (FLGT) Q1 2026 Earnings Call

Fulgent Genetics, Inc. (NASDAQ: FLGT) Q1 2026 earnings conference call, held 2026-05-01. Replay captured from the company's public earnings webcast.

Fri, May 1, 2026 at 8:30 AMendedReplay
Fulgent Genetics, Inc. (FLGT) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Lauren Sloan

Investor Relations

Ming Hsieh

Chief Executive Officer

Brandon Perthes

Chief Commercial Officer

Paul Kim

Chief Financial Officer

Lou Lee

Analyst, UBS

David Westernberg

Analyst, Piper Sandler

Replay transcript excerpt

Greetings. Welcome to Fulgent Genetics first quarter 2026 conference call and webcast. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to Lauren Sloan, Investor Relations. Thank you. You may begin. Good morning and welcome to Fulgent's first quarter 2026 financial results conference call. On the call are Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthes, Chief Commercial Officer. The company's press release discussing the financial results is available on the investor relations section of the company's website, ir.fulgentgenetics.com. A replay of this call will be available shortly after the call concludes on the investor relations section of the company's website. Management's prepared remarks and answers to your question on today's call will contain forward-looking statements. These forward-looking statements represent management's estimates based on current views, expectations, and assumptions, which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties, and changes in circumstances that may cause actual results to differ from those described in the forward-looking statements. The company assumes no obligation to update any of the forward-looking statements it may make today to reflect actual results or changes in expectations. Listeners should not rely on any forward-looking statements as predictions of future events and should listen to management's remarks today with the understanding that actual ...

More from Fulgent Genetics, Inc.